Good
Partially Aligned
Patient Risk:
Low
Summary
Most claims match label-supported information (notably the 5-day adult dosing example, once-daily timing, and with/without food instruction). Several additional claims (missed dose handling, fixed vs weight-based pediatric approach, and generalized “avoid” language for liver/QT/allergy) are either not supported or not directly stated in the provided excerpts, and one claim (pediatric dosing “typically” based on mg/kg) is only partially supported.
Category Scores
Accurate Statements
Zithromax Z-Pak (azithromycin) is typically dosed as a 5-day schedule for adults.
Section 2.1 includes: 500 mg Day 1 followed by 250 mg once daily Days 2 through 5.
On day 1 of the Z-Pak schedule, adults take 500 mg azithromycin once daily.
Section 2.1: 500 mg Day 1 followed by 250 mg once daily Days 2 through 5.
On days 2 through 5 of the Z-Pak schedule, adults take 250 mg azithromycin once daily.
Section 2.1: 500 mg Day 1 followed by 250 mg once daily Days 2 through 5.
The 5-day Z-Pak schedule totals 1.5 g of azithromycin over 5 days.
Implied by the label example dosing: 500 mg (Day 1) + 250 mg/day (Days 2-5) = 500 + 250*4 = 1500 mg.
Azithromycin is typically instructed to be taken once per day at the same time each day.
Supported directionally by “once daily” dosing in Section 2.1 (though the exact phrasing about “same time each day” is not explicitly shown in the excerpts).
Azithromycin can generally be taken with or without food.
Section 2: “ZITHROMAX tablets can be taken with or without food.”
Dose and duration of azithromycin vary by infection type.
Section 1: “Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications.”
Unsupported Statements
Taking azithromycin with food may help reduce stomach upset.
The provided excerpts only state tablets can be taken with or without food (Section 2) and do not claim a benefit of reducing stomach upset.
Pediatric dosing of Zithromax is typically based on weight (mg/kg) and the specific infection being treated.
The excerpts show pediatric regimens expressed as mg/kg and vary by indication (Section 2.2). However, “typically” and the word “specific infection being treated” are not directly stated as such; only selected dose examples are provided.
For children prescribed Zithromax, the clinician calculates the correct mg/kg regimen rather than using the fixed adult Z-Pak dosing.
Section 2.2 provides mg/kg pediatric examples, but it does not explicitly state that clinicians calculate pediatric regimens or that fixed adult Z-Pak dosing should not be used.
If a dose of azithromycin is missed, the typical approach is to take it as soon as possible the same day, then resume the once-daily schedule the next day.
Missed-dose instructions are not present in the provided excerpts.
If a missed dose is close to the next scheduled dose, the missed dose is usually skipped.
Missed-dose instructions are not present in the provided excerpts.
Clinicians may avoid azithromycin if the patient has a known drug allergy to macrolides/azithromycin.
The excerpt lists contraindications for known hypersensitivity to azithromycin/erythromycin/any macrolide or ketolide (Section 4.1), but the claim is framed as “may avoid” rather than reflecting contraindication language.
Clinicians may avoid azithromycin if the patient has certain heart rhythm concerns, such as known QT prolongation.
The excerpt includes QT prolongation risk (Section 5.4) but does not provide a “known QT prolongation” avoidance instruction or contraindication.
Clinicians may avoid azithromycin if the patient has significant liver issues.
The excerpt shows a specific contraindication: history of cholestatic jaundice/hepatic dysfunction associated with prior azithromycin use (Section 4.2) and warnings about hepatotoxicity (Section 5.2). It does not support a generalized “significant liver issues” avoidance statement.
Contradictions
Important Omissions
No claim addressed the label limitations of use for pneumonia requiring factors such as hospitalization, nosocomial infection, bacteremia, or inability for oral therapy (Section 1.3).
Importance:
Moderate
No claim addressed key safety/precautions such as serious allergic reactions, hepatotoxicity discontinuation guidance, QT/torsades risk, or C. difficile-associated diarrhea (Sections 5.1, 5.2, 5.4, 5.6).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Most dosing-related claims align with the provided adult Zithromax regimen. However, missed-dose guidance and generalized avoidance language for QT/liver/allergy are not supported by the excerpts, which could lead to inaccurate use decisions if taken as label-consistent instructions.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
Several non-label-supported generalizations (missed dose instructions; “avoid” language for QT and generalized liver issues; and adult-vs-pediatric calculation phrasing) are included without support in the provided label excerpts.
Suggested Improvement
Limit dosing statements to label-provided regimens (e.g., 500 mg Day 1 then 250 mg Days 2-5; pediatric mg/kg examples). Remove or qualify claims not present in the provided excerpts (missed dose handling; generalized QT/liver avoidance; “may help reduce stomach upset” with food; clinician-calculation phrasing). For safety, rely on the label’s specific contraindication language (Section 4.1/4.2) and warnings rather than generalized avoidance advice (Sections 5.2/5.4).